Mirae Asset Global Investments Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,077 shares of RARE stock, worth $131,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,077
Previous 3,333
7.68%
Holding current value
$131,049
Previous $185,000
30.27%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$427 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$239 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$183 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$107 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.98B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...